M. Tisdale

发表

Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.

S. Mahony, M. Tisdale, 1988, British Journal of Cancer.

Big Green Business

M. Tisdale, H. Mulligan, H. Mulligan, 1993, Environmental Health Perspectives.

Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF)

M. Tisdale, K. Mirza, S. Wyke, 2011, British Journal of Cancer.

Metabolic effects of tumour necrosis factor alpha in NMRI mice.

S. Mahony, M. Tisdale, 1990, British Journal of Cancer.

Role of prostaglandins in tumour necrosis factor induced weight loss.

S. Mahony, M. Tisdale, 1989, British Journal of Cancer.

Reversal of weight loss induced by tumour necrosis factor-alpha.

S. Mahony, M. Tisdale, 1989, Cancer letters.

The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCg) Attenuates Skeletal Muscle Atrophy in a Rat Model of Sarcopenia.

M. Tisdale, S. Pereira, N. Edens, 2015, The Journal of frailty & aging.

Effect of insulin on weight loss and tumour growth in a cachexia model.

M. Tisdale, S. A. Beck, SA Beck, 1989, British Journal of Cancer.

Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle.

M. Tisdale, K. Mirza, 2012, Cellular signalling.

Tumour-associated hypoglycaemia in a murine cachexia model.

M. Tisdale, T. McDevitt, 1992, British journal of cancer.

Role of protein kinase C and NFk B in proteolysis-inducing factor-induced proteasome expression in C 2 C 12 myotubes

M. Tisdale, S. Wyke, Hj Smith, 2004 .

Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.

I. Ferrier, P. Groundwater, M. Tisdale, 1990, British Journal of Cancer.

Guinea worm gone.

M. Tisdale, TM McDevitt, 1993, British Journal of Cancer.

Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor

K. Fearon, S. Wigmore, M. Tisdale, 2000, The British journal of surgery.

Effect of the specific cyclooxygenase‐2 inhibitor meloxicam on tumour growth and cachexia in a murine model

M. Tisdale, M. Tisdale, H. Hussey, 2000, International journal of cancer.

Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle

M. Tisdale, K. Mirza, 2014, British Journal of Cancer.

Alteration ofserumandurinary lipolytic activity withweight loss in cachectic cancerpatients

I. Ferrier, P. Groundwater, M. Tisdale, 1990 .

Induction of muscle protein degradation by a tumour factor.

M. Tisdale, M. Tisdale, P. Cariuk, 1997, British Journal of Cancer.

Mechanism of muscle protein degradation induced by a cancer cachectic factor.

M. Tisdale, M. Tisdale, M. Lorite, 1998, British Journal of Cancer.

Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients

R. Skipworth, K. Fearon, M. Tisdale, 2007, British Journal of Cancer.

Inhibition of tumour growth by lipoxygenase inhibitors.

M. Tisdale, M. Tisdale, H. Hussey, 1996, British Journal of Cancer.

Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.

H. D. Mulligan, M. Tisdale, M. Tisdale, 1991, British Journal of Cancer.

Mechanism of muscle protein degradation in cancer cachexia.

M. Tisdale, M. Tisdale, K. Smith, 1993, British Journal of Cancer.

Reduction of weight loss and tumour size in a cachexia model by a high fat diet.

R. A. Brennan, K. Fearon, M. Tisdale, 1987, British Journal of Cancer.

Effect of insulin on weight loss and tumour growth in a cachexia model.

Siglas de Palabras, M. Tisdale, SA Beck, 1989, British Journal of Cancer.